Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2018

Open Access 01-12-2018 | Research

The knowledge, attitudes and practices of doctors regarding antibiotic resistance at a tertiary care institution in the Caribbean

Authors: Alison Nicholson, Ingrid Tennant, Livingston White, Camille-Ann Thoms-Rodriguez, Loraine Cook, Stephen Johnson, Tamara Thompson, Jasper Barnett, Lundie Richards

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2018

Login to get access

Abstract

Background

Antibiotic resistance (ABR) is a serious threat that requires coordinated global intervention to prevent its spread. There is limited data from the English-speaking Caribbean.

Methods

As part of a national programme to address antibiotic resistance in Jamaica, a survey of the knowledge, attitudes and antibiotic prescribing practices of Jamaican physicians was conducted using a 32-item self-administered questionnaire.

Results

Of the eight hundred physicians targeted, 87% responded. The majority thought the problem of resistance very important globally (82%), less nationally (73%) and even less (53%) in personal practices. Hospital physicians were more likely to consider antibiotic resistance important in their practice compared to those in outpatient practice or both (p < 0.001). Composite knowledge scores were generated and considered good if scored > 80%, average if 60–79% and poor if < 60%. Most had good knowledge of factors preventing resistance (83%) and resistance inducing potential of specific antibiotics (59%), but only average knowledge of factors contributing to resistance (57%). Knowledge of preventative factors was highest in females (p = 0.004), those with postgraduate training (p = 0.001) and those > four years post graduation (p = 0.03). Empiric therapy was often directed by international guidelines and cultures were not routinely done. Limited laboratory and human resources were identified as challenges.

Conclusion

Physicians in this study were aware of the problem of ABR, but downplayed its significance nationally and personally. These results will guide a national antibiotic stewardship programme.
Literature
1.
go back to reference Levy SB, O'Brien TF. Global Antimicrobial Resistance Alerts and Implications. CID. 2005;41:219–20. (Suppl 4)CrossRef Levy SB, O'Brien TF. Global Antimicrobial Resistance Alerts and Implications. CID. 2005;41:219–20. (Suppl 4)CrossRef
2.
go back to reference Livermore D. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012;27:28–142.CrossRef Livermore D. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012;27:28–142.CrossRef
3.
go back to reference Laxminarayan R, Duse A, Wattal C, Zaidi A, Wertheim H, Sump N, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–98.CrossRefPubMed Laxminarayan R, Duse A, Wattal C, Zaidi A, Wertheim H, Sump N, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–98.CrossRefPubMed
4.
go back to reference Ventola C. The antibiotic resistance crisis. Pharm Ther. 2015;40(4):277–83. Ventola C. The antibiotic resistance crisis. Pharm Ther. 2015;40(4):277–83.
7.
go back to reference Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:1–5.CrossRef Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:1–5.CrossRef
8.
go back to reference Akpaka PE, Swanston WH. Phenotypic detection and occurrence of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli at a tertiary Hospital in Trinidad & Tobago. Braz J Infect Dis. 2016;12(6):516–20.CrossRef Akpaka PE, Swanston WH. Phenotypic detection and occurrence of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli at a tertiary Hospital in Trinidad & Tobago. Braz J Infect Dis. 2016;12(6):516–20.CrossRef
11.
go back to reference Hariharan S, Nanduri SB, Moseley HS, Areti KY, Jonnalagadda R. Spectrum of microbes and antimicrobial resistance in a surgical intensive care unit. Am J Infect Control. 2003;31(5):280–7.CrossRefPubMed Hariharan S, Nanduri SB, Moseley HS, Areti KY, Jonnalagadda R. Spectrum of microbes and antimicrobial resistance in a surgical intensive care unit. Am J Infect Control. 2003;31(5):280–7.CrossRefPubMed
12.
go back to reference Levett PN, Holt HA, McGowan AP. Resistance to third-generation cephalosporins in Barbados. West Indian Med J. 1993;42(2):69–71.PubMed Levett PN, Holt HA, McGowan AP. Resistance to third-generation cephalosporins in Barbados. West Indian Med J. 1993;42(2):69–71.PubMed
13.
go back to reference Thoms-Rodriguez CA, Mazzulli T, Christian N, Willey B, Boyd DA, Mataseje LF, et al. New Delhi metallo-β-lactamase in Jamaica. J Infect Dev Ctries. 2016;10(2):183–7.CrossRefPubMed Thoms-Rodriguez CA, Mazzulli T, Christian N, Willey B, Boyd DA, Mataseje LF, et al. New Delhi metallo-β-lactamase in Jamaica. J Infect Dev Ctries. 2016;10(2):183–7.CrossRefPubMed
14.
go back to reference Souli M, Galani I, Giamarellou H. Emergence Of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe. Euro Surveill. 2008;47(13):1–11. Souli M, Galani I, Giamarellou H. Emergence Of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe. Euro Surveill. 2008;47(13):1–11.
16.
go back to reference Nicholson AM, Ledgister S, Williams T, Robinson S, Gayle P, Lindo T, et al. Distribution of nosocomial organisms and their resistance patterns in the intensive care unit of the University Hospital of the West Indies, Kingston. Jam W Indian Med J. 2009;58(2):142–8. (ISSN 0043-3144) Nicholson AM, Ledgister S, Williams T, Robinson S, Gayle P, Lindo T, et al. Distribution of nosocomial organisms and their resistance patterns in the intensive care unit of the University Hospital of the West Indies, Kingston. Jam W Indian Med J. 2009;58(2):142–8. (ISSN 0043-3144)
18.
go back to reference Hamilton-Miller JMT. Use and abuse of antibiotics. Br J Clin Pharm. 1984;18:469–74.CrossRef Hamilton-Miller JMT. Use and abuse of antibiotics. Br J Clin Pharm. 1984;18:469–74.CrossRef
19.
go back to reference Tennant I, Nicholson A, Gordon-Strachan GM, Thoms C, Chin V, Didier MA. A survey of physicians’ knowledge and attitudes regarding antimicrobial resistance and antibiotic prescribing practices at the university hospital of the west indies. W Indian Med J. 2010;59(2):165–70.PubMed Tennant I, Nicholson A, Gordon-Strachan GM, Thoms C, Chin V, Didier MA. A survey of physicians’ knowledge and attitudes regarding antimicrobial resistance and antibiotic prescribing practices at the university hospital of the west indies. W Indian Med J. 2010;59(2):165–70.PubMed
22.
go back to reference The World Health Organization. Second Meeting of the Subcommittee of the Expert Committee on the Selection and Use of Essential Medicines. Use of Ceftazidime in Children and Options for Treating Pseudomonas Infections. Geneva : s.n., 2008. The World Health Organization. Second Meeting of the Subcommittee of the Expert Committee on the Selection and Use of Essential Medicines. Use of Ceftazidime in Children and Options for Treating Pseudomonas Infections. Geneva : s.n., 2008.
23.
go back to reference Pedhazur EJ, Pedhazur-Schmelkin LP. Measurement, design and analysis: an integrated approach. New York: Psychology Press; 1991. p. 109. Pedhazur EJ, Pedhazur-Schmelkin LP. Measurement, design and analysis: an integrated approach. New York: Psychology Press; 1991. p. 109.
24.
go back to reference Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect. 2010;18(16):1062–9.CrossRef Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect. 2010;18(16):1062–9.CrossRef
25.
go back to reference Society for Healthcare Epidemiology of America and Infectious Diseases Society of America. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012;33(4):322–3.CrossRef Society for Healthcare Epidemiology of America and Infectious Diseases Society of America. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012;33(4):322–3.CrossRef
27.
go back to reference Ruiza J, Jurado A, Garcia-Méndez E, Marco F, Aguilar L, Jiménez de Anta T, et al. Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones. J Antimicrob Chemother. 2001;48(4):545–8.CrossRef Ruiza J, Jurado A, Garcia-Méndez E, Marco F, Aguilar L, Jiménez de Anta T, et al. Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones. J Antimicrob Chemother. 2001;48(4):545–8.CrossRef
28.
go back to reference Brown P. Multiple-locus VNTR analyses of methicillin-resistant Staphylococcus aureus from Jamaica. Infect Dis (Auckl). 2015;8:31–8.CrossRefPubMed Brown P. Multiple-locus VNTR analyses of methicillin-resistant Staphylococcus aureus from Jamaica. Infect Dis (Auckl). 2015;8:31–8.CrossRefPubMed
29.
go back to reference Nicholson AM, Thoms C, Wint H, Didier M, Willis R, McMorris N, et al. The detection of mupirocin resistance and the distribution of methicillin-resistant Staphylococcus aureus at the University Hospital of the West Indies, Jamaica. West Indian Med J. 2010;59(5):509–13.PubMed Nicholson AM, Thoms C, Wint H, Didier M, Willis R, McMorris N, et al. The detection of mupirocin resistance and the distribution of methicillin-resistant Staphylococcus aureus at the University Hospital of the West Indies, Jamaica. West Indian Med J. 2010;59(5):509–13.PubMed
30.
go back to reference Whitney C, Farley M, Hadler J, Harrison L, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917–192.CrossRefPubMed Whitney C, Farley M, Hadler J, Harrison L, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917–192.CrossRefPubMed
32.
go back to reference Hayashi Y, Paterson D. Strategies for reduction in duration of antibiotic use in hospitalized patients. CID. 2011;52:1232–40.CrossRef Hayashi Y, Paterson D. Strategies for reduction in duration of antibiotic use in hospitalized patients. CID. 2011;52:1232–40.CrossRef
33.
go back to reference Chin V, Harding HE, Tennant I, Soogrim D, Gordon-Strachan GM, Frankson MA. Dynamics of antibiotic usage in the intensive care unit at the University Hospital of the West Indies. West Indian Med J. 2010;59(2):159–64.PubMed Chin V, Harding HE, Tennant I, Soogrim D, Gordon-Strachan GM, Frankson MA. Dynamics of antibiotic usage in the intensive care unit at the University Hospital of the West Indies. West Indian Med J. 2010;59(2):159–64.PubMed
Metadata
Title
The knowledge, attitudes and practices of doctors regarding antibiotic resistance at a tertiary care institution in the Caribbean
Authors
Alison Nicholson
Ingrid Tennant
Livingston White
Camille-Ann Thoms-Rodriguez
Loraine Cook
Stephen Johnson
Tamara Thompson
Jasper Barnett
Lundie Richards
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2018
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-018-0315-3

Other articles of this Issue 1/2018

Antimicrobial Resistance & Infection Control 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.